Skip to main content
Skip to main content
CSNVY logo

Corbion N.V. (CSNVY)

$23.50 $-0.60 (-2.49%) |CouncilHOLD · 38 · D
Bottom line: HOLD — our Council read (38/100) and AI Score (38/100) broadly agree.
MCap: $1.35B| P/E Ratio: 14.6| Vol: 900| 52-wk range: $19.81 – $25.50
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Corbion N.V. (CSNVY) trades at $23.50 with AI Score 38/100 (Grade D). Corbion N. V. is a global leader in bio-based ingredients, manufacturing lactic acid, emulsifiers, and other solutions from renewable materials. Market cap: $1.35B, Sector: Basic materials.

Price live · AI analysis from Jun 15, 2026
Corbion N.V. is a global leader in bio-based ingredients, manufacturing lactic acid, emulsifiers, and other solutions from renewable materials. The company serves diverse industries including food, personal care, pharmaceuticals, and bioplastics, addressing the growing demand for sustainable products worldwide.

Analyst Coverage for CSNVY: CSNVY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CSNVY against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 38/100 · D

CSNVY: 1/1 perspectives are bearish.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Corbion N.V. (CSNVY) Materials & Commodity Exposure

CEOOlivier Rigaud
Employees2383
HeadquartersAmsterdam, NL
IPO Year2011

Corbion N.V. (CSNVY) is a Dutch global leader in bio-based ingredients, specializing in lactic acid and derivatives for diverse sectors like food, personal care, and bioplastics. Leveraging renewable resources, the company addresses growing consumer demand for sustainable and natural solutions across international markets, maintaining a strong position in specialty chemicals.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 15, 2026

What Is the Investment Thesis for CSNVY?

Corbion N.V. (CSNVY) presents a compelling profile as a global leader in bio-based ingredients, strategically positioned to capitalize on the escalating demand for sustainable and natural solutions across multiple industries. With a market capitalization of $1.35B and a P/E ratio of 14.6, the company demonstrates a stable valuation within its sector. Its robust gross margin of 26.1% and a profit margin of 5.9% underscore efficient operations and profitability. A significant value driver is Corbion's expertise in lactic acid and its derivatives, which are crucial for the burgeoning bioplastics market, offering substantial long-term growth potential. The company's diversified product portfolio and broad industrial applications, spanning food, personal care, and pharmaceuticals, mitigate reliance on any single market segment. Furthermore, a dividend yield of 4.76% provides income potential for investors. Key growth catalysts include the increasing consumer preference for clean-label products and the regulatory push towards bio-based materials. However, as an ADR trading on the OTC Other tier, liquidity risks and disclosure limitations warrant careful consideration, alongside potential volatility from raw material price fluctuations.

Based on FMP financials and quantitative analysis

CSNVY Key Highlights

  • Market Capitalization of $1.35B, reflecting its standing as a significant player in the specialty chemicals sector.
  • Price-to-Earnings (P/E) ratio of 15.41, indicating its valuation relative to earnings within the industry.
  • Profit Margin of 5.9%, demonstrating the company's efficiency in converting revenue into net income.
  • Gross Margin of 26.1%, showcasing the profitability of its core product sales before operating expenses.
  • Dividend Yield of 4.76%, offering a return to shareholders based on its current stock price and dividend payments.

Who Are CSNVY's Competitors?

CSNVY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
DALQF D&L Industries, Inc. $0.13 +21.23% $22.95B 54
HGRAF HydroGraph Clean Power Inc. $3.43 -3.11% $1.20B 69
LWLG Lightwave Logic, Inc. $7.46 +1.29% $1.15B 69
COOSF Carbios SAS $6.50 -9.09% $109.66M 69
NVZMY Novozymes A/S $63.45 -2.53% $29.58B 62
ELKEF Elkem ASA $3.40 +0.00% $2.16B 50
GVDBF Givaudan S.A. $3440.15 -18.91% $31.75B 50
AVNT Avient Corporation $38.83 +4.07% $3.56B 50

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CSNVY's Key Strengths?

  • Global leadership in lactic acid and derivatives, a foundational bio-based ingredient.
  • Diverse product portfolio serving multiple resilient industries (food, pharma, bioplastics).
  • Strong commitment to sustainability and renewable resources, aligning with market trends.
  • Established global sales and distribution network.
  • Robust R&D capabilities driving innovation in bio-based solutions.

What Are CSNVY's Weaknesses?

  • Exposure to raw material price fluctuations, impacting cost of goods sold.
  • Reliance on fermentation processes which can be sensitive to operational disruptions.
  • As an ADR on OTC Other tier, potential for lower liquidity and less transparent disclosure.
  • Beta of 0.93 indicates some market sensitivity, though slightly less volatile than the broader market.
  • Profit margin of 5.9% suggests room for further operational efficiency improvements.

What Could Drive CSNVY Stock Higher?

  • Continued expansion in the bioplastics market, driven by new product launches and increased adoption of PLA-based materials globally, potentially boosting demand for Corbion's lactic acid derivatives.
  • Growing consumer and industrial preference for sustainable and natural ingredients, which directly aligns with Corbion's core bio-based product portfolio, driving consistent demand across sectors.
  • Successful integration of new fermentation technologies or process optimizations that could enhance production efficiency and reduce costs, improving profit margins.
  • Strategic partnerships or collaborations with major food, personal care, or bioplastics companies to co-develop innovative solutions, expanding market reach and application areas.

What Are the Key Risks for CSNVY?

  • Fluctuations in raw material prices, particularly for agricultural feedstocks used in fermentation, could impact Corbion's cost of goods sold and profitability.
  • Increased competition from other specialty chemical manufacturers or new entrants in the bio-based ingredients market, potentially leading to pricing pressures or market share erosion.
  • The inherent liquidity risks associated with trading on the OTC Other tier, which could lead to wider bid-ask spreads and difficulty in executing trades efficiently for investors.
  • Adverse currency exchange rate movements between the Euro and the U.S. Dollar, which could negatively affect the value of CSNVY ADRs for U.S. investors.
  • Regulatory changes or stricter environmental standards in key operating regions, which could necessitate significant investments in compliance or alter product demand.

What Are the Growth Opportunities for CSNVY?

  • Growth opportunity 1: The escalating global demand for sustainable and natural ingredients represents a significant driver for Corbion. Consumers are increasingly seeking products with transparent sourcing and minimal environmental impact, particularly in the food and beverage, and home and personal care sectors. Corbion's entire portfolio, derived from renewable resources like lactic acid, directly addresses this trend. The market for natural food ingredients alone is projected to reach substantial figures, with Corbion positioned to capture a larger share through its established product lines and continuous innovation in bio-based alternatives. This trend is ongoing and expected to intensify over the next decade, providing a robust foundation for consistent revenue growth.
  • Growth opportunity 2: Expansion in the bioplastics market, particularly through its lactic acid derivatives, offers a high-potential growth avenue. Lactic acid is a primary building block for polylactic acid (PLA), a biodegradable and compostable bioplastic. As regulatory pressures increase and corporate sustainability commitments grow, the adoption of bioplastics in packaging, textiles, and other applications is accelerating. The global bioplastics market is anticipated to grow at a double-digit CAGR over the next five to ten years, reaching tens of billions of dollars. Corbion's foundational role in the PLA value chain positions it to benefit directly from this market expansion, leveraging its expertise to supply critical raw materials for sustainable plastic alternatives.
  • Growth opportunity 3: Innovation within the food and beverage industry, driven by health and wellness trends, presents ongoing opportunities. Corbion's functional ingredients, such as emulsifiers, minerals, and enzyme blends, enable food manufacturers to develop products that meet consumer preferences for reduced sugar, salt, and fat, while maintaining taste and texture. The demand for fortified foods, extended shelf-life solutions, and plant-based alternatives continues to expand globally. Corbion's R&D capabilities allow it to collaborate with customers to create bespoke solutions, ensuring its relevance in a rapidly evolving market. This continuous innovation cycle is a perpetual growth driver, with new product development cycles typically spanning 1-3 years.
  • Growth opportunity 4: The increasing adoption of bio-based ingredients in the home and personal care sector provides another significant growth pathway. Consumers are actively seeking natural and environmentally friendly options for cosmetics, detergents, and other household products. Corbion's ingredients, including lactic acid for pH regulation and preservation, and specialized emulsifiers, are ideal for formulating 'clean label' personal care products. This market segment is experiencing strong growth, with consumers willing to pay a premium for sustainable and non-toxic alternatives. Corbion's ability to supply high-quality, renewable ingredients positions it to be a preferred partner for brands looking to reformulate their product lines to meet these evolving consumer demands, with market shifts occurring over a 3-5 year horizon.
  • Growth opportunity 5: The animal nutrition sector offers further growth potential, driven by the global demand for sustainable and efficient livestock production. Corbion's portfolio includes ingredients that enhance animal health, improve feed efficiency, and reduce the environmental footprint of animal agriculture. As the world's population grows, so does the demand for protein, necessitating more sustainable and productive animal farming practices. Corbion's solutions contribute to gut health, pathogen control, and overall animal welfare, aligning with industry trends towards responsible animal husbandry. This market segment provides a stable and expanding demand base, with product adoption cycles typically ranging from 2-4 years as new feed formulations are introduced.

What Opportunities Does CSNVY Have?

  • Growing global demand for sustainable, natural, and clean-label ingredients across all sectors.
  • Expansion of the bioplastics market, driven by environmental concerns and regulatory support.
  • Increased adoption of bio-based solutions in home and personal care products.
  • Potential for strategic acquisitions or partnerships to expand product offerings or market reach.
  • Innovation in new applications for existing ingredients, opening new revenue streams.

What Threats Does CSNVY Face?

  • Intense competition from both established chemical giants and emerging bio-ingredient producers.
  • Regulatory changes impacting the use or production of certain ingredients.
  • Economic downturns affecting demand in key industrial sectors.
  • Technological disruptions or new production methods by competitors.
  • Supply chain vulnerabilities or geopolitical events affecting raw material availability.

What Are CSNVY's Competitive Advantages?

  • Proprietary fermentation technology and expertise in producing lactic acid and its derivatives at scale.
  • Diversified product portfolio and broad application across multiple, essential industries, reducing reliance on single markets.
  • Global distribution network and established customer relationships built over decades.
  • Strong focus on sustainability and renewable resources, aligning with growing market and regulatory demands.
  • Continuous investment in research and development to innovate and maintain a competitive edge in bio-based solutions.

What Does CSNVY Do?

Corbion N.V. is a global enterprise headquartered in Amsterdam, the Netherlands, with a rich history dating back to its founding in 1919. Initially known as CSM N.V., the company underwent a significant transformation and rebranded as Corbion N.V. in October 2013, solidifying its focus on bio-based ingredients. The company is a prominent manufacturer and supplier of a diverse range of ingredients, all meticulously sourced from renewable materials. Its extensive product portfolio is a testament to its commitment to innovation and sustainability, encompassing core offerings such as lactic acid and its various derivatives, specialized emulsifiers crucial for product stability, advanced functional enzyme blends, essential minerals, vitamins, and innovative algae-based components. These sophisticated solutions are integral to a broad spectrum of industries, demonstrating Corbion's pervasive market reach. Key sectors served include the food and beverage industry, where its ingredients enhance taste, texture, and shelf-life; the home and personal care products market, contributing to efficacy and natural formulations; pharmaceuticals, providing critical components; animal nutrition, supporting health and growth; medical devices, ensuring biocompatibility; and the rapidly expanding bioplastics sector, where its lactic acid derivatives are foundational. Corbion N.V. ensures its global presence and accessibility through a well-established international network comprising numerous sales offices and authorized distributors, facilitating efficient delivery of its specialized ingredients to customers across continents.

What Products and Services Does CSNVY Offer?

  • Manufacture and supply lactic acid and its various derivatives, fundamental to many industrial applications.
  • Produce specialized emulsifiers that enhance product stability and texture in food and personal care items.
  • Develop advanced functional enzyme blends used to improve processing efficiency and product quality.
  • Provide essential minerals and vitamins for nutritional enrichment in food, animal feed, and pharmaceuticals.
  • Innovate with algae-based components, offering sustainable solutions for various industries.
  • Supply ingredients for the food and beverage industry, including preservatives, acidulants, and texture enhancers.
  • Offer solutions for home and personal care products, contributing to natural and effective formulations.
  • Produce components for the pharmaceutical and medical device sectors, ensuring high purity and performance.
  • Develop materials for the bioplastics industry, enabling the creation of biodegradable and compostable plastics.

How Does CSNVY Make Money?

  • Research, develop, and produce bio-based ingredients from renewable raw materials.
  • Sell a diverse portfolio of specialty ingredients to business-to-business (B2B) customers across multiple industries.
  • Leverage a global network of sales offices and distributors to reach international markets efficiently.
  • Focus on high-value, specialized applications where their bio-based solutions offer distinct advantages.
  • Engage in long-term partnerships with customers to co-develop tailored ingredient solutions.

What Industry Does CSNVY Operate In?

Corbion N.V. operates within the dynamic and innovation-driven specialty chemicals industry, specifically focusing on bio-based ingredients. This sector is characterized by a strong emphasis on research and development, driven by increasing consumer and industrial demand for sustainable, natural, and high-performance solutions. Corbion's positioning as a key supplier of lactic acid, emulsifiers, and other renewable-sourced ingredients places it at the forefront of several significant market trends, including the clean label movement in food, the shift towards bio-degradable materials in packaging (bioplastics), and the growing preference for natural components in home and personal care products. The competitive landscape includes both large diversified chemical companies and specialized bio-ingredient producers. Corbion differentiates itself through its deep expertise in fermentation technology and its integrated value chain from raw materials to specialized applications, allowing it to maintain a competitive edge in delivering tailored solutions to its global customer base.

Who Are CSNVY's Key Customers?

  • Food and beverage manufacturers seeking natural preservatives, emulsifiers, and functional ingredients.
  • Companies in the home and personal care sector formulating sustainable and clean-label products.
  • Pharmaceutical and medical device companies requiring high-purity bio-based components.
  • Animal nutrition companies developing advanced feed additives for health and efficiency.
  • Bioplastics producers utilizing lactic acid as a key monomer for biodegradable polymers.
AI Confidence: 69% Updated: Jun 15, 2026

ROE 10%Key Financial Metrics

Return on equity for Corbion N.V. stands at 10.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.3%, showing how much profit it generates from its asset base. CSNVY trades at a trailing price-to-earnings ratio of 14.65, below the Basic Materials sector average of ~22x. Its free cash flow yield is 8.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.89 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.4%, the inverse of the P/E and a quick read on earnings relative to price.

Corbion N.V. (CSNVY) Valuation Context

Valued at $1.35B, CSNVY is classified as a small-cap stock. Relative to its peer group, CSNVY's quantitative score of 38/100 is below the peer average of 65/100.

Company Profile

Corbion N.V. operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Amsterdam, NL. The company is led by CEO Olivier Rigaud. CSNVY has traded publicly since 2011.

F-Score 7/9Financial Health

Corbion N.V.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.28 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2026 estForward Outlook

Wall Street analysts project Corbion N.V. revenue of about $1.28B for fiscal 2026, with EPS near $0.00. The estimate reflects 7 contributing analysts.

CSNVY Financials

Fundamental Snapshot

Revenue Growth (FY)
-1.6%
Net Income Growth (FY)
-62.6%
EPS Growth (FY)
-62.3%
Free Cash Flow Growth (FY)
-10.9%
P/E (TTM)
15.6
Return on Equity (TTM)
+10.2%
Current Ratio
1.9
EV/EBITDA (TTM)
7.9

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Global leadership in lactic acid and derivatives, a foundational bio-based ingredient.
  • Diverse product portfolio serving multiple resilient industries (food, pharma, bioplastics).
  • Strong commitment to sustainability and renewable resources, aligning with market trends.
  • Established global sales and distribution network.

Bear Case

  • Exposure to raw material price fluctuations, impacting cost of goods sold.
  • Reliance on fermentation processes which can be sensitive to operational disruptions.
  • As an ADR on OTC Other tier, potential for lower liquidity and less transparent disclosure.
  • Beta of 0.93 indicates some market sensitivity, though slightly less volatile than the broader market.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

CSNVY Latest News

CSNVY Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CSNVY.

Price Targets

Wall Street price target analysis for CSNVY.

CSNVY MoonshotScore

38/100

What does this score mean?

The MoonshotScore rates CSNVY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Olivier Rigaud

Chief Executive Officer

Unknown. Specific details regarding Olivier Rigaud's career history, educational background, previous roles, and credentials are not provided in the source data.

Track Record: Unknown. Specific achievements, strategic decisions, or company milestones directly attributable to Olivier Rigaud's leadership are not detailed in the provided information.

Corbion N.V. ADR Information Unsponsored

Corbion N.V. trades as an American Depositary Receipt (ADR) under the ticker CSNVY, allowing U.S. investors to own shares of a foreign company without directly trading on its home exchange. Each ADR represents a certain number of underlying shares of Corbion N.V. common stock, which are held by a U.S. depositary bank. This structure simplifies cross-border investing by handling foreign currency conversions and local market settlement, making the shares more accessible to a broader investor base in the United States.

  • Home Market Ticker: Euronext Amsterdam, Netherlands
  • ADR Level: 1
  • ADR Ratio: 1:1
  • Home Market Ticker: CSNV
Currency Risk: Investors holding CSNVY ADRs are exposed to currency risk, primarily between the Euro (EUR), Corbion's home currency, and the U.S. Dollar (USD). Fluctuations in the EUR/USD exchange rate can impact the value of the ADRs when converted back to USD, regardless of Corbion's underlying business performance. A strengthening USD against the EUR would reduce the dollar value of Corbion's earnings and dividends for U.S. investors, while a weakening USD would have the opposite effect, affecting overall investment returns.
Tax Implications: Dividends paid by Corbion N.V. to ADR holders may be subject to foreign dividend withholding tax by the Dutch government. The standard withholding tax rate in the Netherlands is 15%. However, the actual rate applied to U.S. investors can be reduced by tax treaties between the United States and the Netherlands, which typically allow for a lower rate, often 15%, for eligible investors. Investors should consult tax professionals regarding specific implications and potential for tax credits.
Trading Hours: Corbion N.V.'s underlying shares (CSNV) trade on Euronext Amsterdam, which operates during European market hours (typically 9:00 AM to 5:30 PM CET). In contrast, CSNVY ADRs trade on the U.S. OTC market during U.S. trading hours (typically 9:30 AM to 4:00 PM ET). This time difference means that significant news or events released during European trading hours may not be fully reflected in the CSNVY price until the U.S. market opens, potentially leading to price gaps or delayed reactions for U.S. investors.

CSNVY OTC Market Information

Corbion N.V. (CSNVY) trades on the OTC Other tier of the over-the-counter market, which is the lowest and least regulated tier. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, companies on the OTC Other tier are not required to file financial reports with the SEC. This tier includes companies that do not meet the minimum financial or disclosure standards for OTCQX or OTCQB, or those that choose not to provide public disclosure. For investors, this means significantly less transparency and potentially higher risk compared to exchange-listed or even higher-tier OTC stocks, as there is no central marketplace or clearing corporation to guarantee trades.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Trading CSNVY on the OTC Other tier typically entails lower liquidity compared to exchange-listed securities. This means fewer buyers and sellers, which can result in wider bid-ask spreads, making it more expensive to enter or exit positions. Low trading volume can also lead to significant price volatility, as even small trades can have a disproportionate impact on the stock price. Investors may find it difficult to execute large orders without moving the market, and there's a higher risk of not being able to sell shares quickly at a desired price.
OTC Risk Factors:
  • Limited public disclosure and transparency due to the OTC Other tier classification.
  • Lower liquidity and wider bid-ask spreads, making trading potentially more costly and difficult.
  • Increased price volatility due to lower trading volumes and less market oversight.
  • Reduced analyst coverage and institutional interest compared to exchange-listed companies.
  • Potential for less stringent corporate governance standards than those required by major exchanges.
Due Diligence Checklist:
  • Verify the company's financial statements and annual reports directly from its home market (Euronext Amsterdam).
  • Research the company's management team and corporate governance practices.
  • Assess the company's competitive landscape and market position within its industry.
  • Evaluate the company's long-term growth strategy and sustainability initiatives.
  • Understand the specific risks associated with its ADR structure and OTC trading.
  • Monitor news and press releases from the company's official investor relations channels.
  • Consult with a financial advisor experienced in international and OTC investments.
Legitimacy Signals:
  • Corbion N.V. is a long-established company, founded in 1919, indicating a history of operations.
  • It is headquartered in Amsterdam, Netherlands, and trades on Euronext Amsterdam, a regulated European exchange.
  • The company has a significant global presence with 2383 employees and international distribution.
  • Its business model focuses on essential bio-based ingredients, serving diverse and critical industries.
  • The company has a substantial market capitalization of $1.35B, suggesting a recognized market value.

What Investors Ask About Corbion N.V. (CSNVY) — Basic Materials

What does Corbion N.V. do?

Corbion N.V. is a global manufacturer and supplier of bio-based ingredients, specializing in products derived from renewable resources. Its core offerings include lactic acid and its derivatives, which are foundational for various industrial applications, particularly in the rapidly growing bioplastics sector. The company also produces specialized emulsifiers, functional enzyme blends, essential minerals, vitamins, and innovative algae-based components. These ingredients serve a broad array of industries, including food and beverage for preservation and texture, home and personal care for natural formulations, pharmaceuticals for critical components, animal nutrition for health, and medical devices. Corbion distributes its solutions internationally through a robust network, focusing on delivering sustainable and high-performance ingredients to its diverse customer base.

How does Corbion N.V. address sustainability in its operations?

Corbion N.V. places sustainability at the core of its business model, evidenced by its exclusive focus on ingredients sourced from renewable materials. The company's primary products, such as lactic acid, are derived through fermentation processes utilizing biomass, offering a more environmentally friendly alternative to petroleum-based chemicals. This commitment extends to its operational practices, aiming for efficient resource utilization and reduced environmental footprint. By providing solutions for bioplastics, Corbion directly contributes to the circular economy and the reduction of plastic waste. Its ingredients also enable customers in food, personal care, and animal nutrition to develop more sustainable products, aligning with global efforts to mitigate climate change and promote responsible consumption. This comprehensive approach to sustainability is integral to its market positioning and long-term strategy.

What are the key financial metrics investors watch for CSNVY?

Investors monitoring CSNVY typically focus on several key financial metrics to assess its performance and valuation. The company's market capitalization of $1.35B provides an indication of its overall size and market presence. The Price-to-Earnings (P/E) ratio of 15.41 offers insight into how the market values its earnings, comparing it to industry peers. Profit Margin (5.9%) and Gross Margin (26.1%) are crucial for understanding operational efficiency and profitability from its core business activities. Given its dividend yield of 4.76%, dividend sustainability and growth are also important for income-focused investors. Additionally, the Beta of 0.93 suggests its stock volatility relative to the broader market. For a specialty chemicals company like Corbion, monitoring revenue growth, R&D expenditure, and capital allocation for expansion projects is also vital, alongside managing raw material costs.

What are the main risks for CSNVY?

Investing in CSNVY carries several notable risks, stemming from both its operational profile and its trading characteristics. Operationally, the company is exposed to volatility in raw material prices, as its bio-based ingredients rely on agricultural feedstocks, which can impact production costs and profit margins. Intense competition within the specialty chemicals and bio-based ingredients sectors could also exert pressure on pricing and market share. Furthermore, as an American Depositary Receipt (ADR) trading on the OTC Other tier, CSNVY faces specific risks related to lower liquidity, wider bid-ask spreads, and potentially less comprehensive public disclosure compared to exchange-listed securities. Currency fluctuations between the Euro and the U.S. Dollar also introduce foreign exchange risk for U.S. investors, affecting the dollar value of their investment and any dividends received.

What are the key factors to evaluate for CSNVY?

Corbion N.V. (CSNVY) holds an AI score of 38/100 (low). P/E: 14.6x vs the S&P 500's ~20-25x. Not financial advice.

How frequently does CSNVY data refresh on this page?

CSNVY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven CSNVY's recent stock price performance?

Corbion N.V. (CSNVY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Global leadership in lactic acid and derivatives, a foundational bio-based ingredient. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CSNVY overvalued or undervalued right now?

Corbion N.V. (CSNVY) trades at 14.6x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • CEO background and track record details are 'Unknown' due to limited source data, as per instructions.
  • Specific tax implications for ADRs beyond general withholding tax rates are complex and require individual consultation, thus a general statement is provided.
  • The 'Unknown' disclosure status for OTC Other tier means detailed financial reports may not be easily accessible through typical U.S. channels, requiring reliance on home market filings.
Data Sources

Popular Stocks